- Home
- INNV vs BIOA Comparison
INNV vs BIOA Comparison
Compare INNV & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INNV | BIOA |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.4M | 443.9M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | INNV | BIOA |
|---|---|---|
| Price | $5.82 | $19.97 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $5.00 | ★ $13.50 |
| AVG Volume (30 Days) | 113.1K | ★ 762.6K |
| Earning Date | 02-03-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $884,662,000.00 | $5,917,000.00 |
| Revenue This Year | $11.18 | N/A |
| Revenue Next Year | $9.58 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.48 | N/A |
| 52 Week Low | $2.60 | $2.88 |
| 52 Week High | $6.26 | $24.00 |
Technical Indicators
Market Signals| Indicator | INNV | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 57.31 | 67.96 |
| Support Level | $5.21 | $13.66 |
| Resistance Level | $5.86 | $24.00 |
| Average True Range (ATR) | 0.29 | 1.88 |
| MACD | 0.03 | 0.66 |
| Stochastic Oscillator | 75.61 | 67.40 |
Price Performance
Historical ComparisonAbout INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.